Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1500161
European Journal of Endocrinology, Vol 150, Issue 2, 161-171
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lukanova, A
Right arrow Articles by Kaaks, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lukanova, A
Right arrow Articles by Kaaks, R

Clinical Studies

Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women

A Lukanova, E Lundin, A Zeleniuch-Jacquotte, P Muti, A Mure, S Rinaldi, L Dossus, A Micheli, A Arslan, P Lenner, RE Shore, V Krogh, KL Koenig, E Riboli, F Berrino, G Hallmans, P Stattin, P Toniolo, and R Kaaks

Hormones and Cancer Group, International Agency for Research on Cancer, Lyon, France. lukanova@iarc.fr

OBJECTIVE: Excess weight has been associated with increased risk of cancer at several organ sites. In part, this effect may be modulated through alterations in the metabolism of sex steroids and IGF-I related peptides. The objectives of the study were to examine the association of body mass index (BMI) with circulating androgens (testosterone, androstenedione and dehydroepiandrosterone sulfate (DHEAS)), estrogens (estrone and estradiol), sex hormone-binding globulin (SHBG), IGF-I and IGF-binding protein (IGFBP)-3, and the relationship between sex steroids, IGF-I and IGFBP-3. DESIGN AND METHODS: A cross-sectional analysis was performed using hormonal and questionnaire data of 620 healthy women (177 pre- and 443 post-menopausal). The laboratory measurements of the hormones of interest were available from two previous case-control studies on endogenous hormones and cancer risk. RESULTS: In the pre-menopausal group, BMI was not related to androgens and IGF-I. In the post-menopausal group, estrogens, testosterone and androstenedione increased with increasing BMI. The association with IGF-I was non-linear, with the highest mean concentrations observed in women with BMI between 24 and 25. In both pre- and post-menopausal subjects, IGFBP-3 did not vary across BMI categories and SHBG decreased with increasing BMI. As for the correlations between peptide and steroid hormones, in the post-menopausal group, IGF-I was positively related to androgens, inversely correlated with SHBG, and not correlated with estrogens. In the pre-menopausal group, similar but weaker correlations between IGF-I and androgens were observed. CONCLUSIONS: These observations offer evidence that obesity may influence the levels of endogenous sex-steroid and IGF-related hormones in the circulation, especially after menopause. Circulating IGF-I, androgens and SHBG appear to be related to each other in post-menopausal women.


This article has been cited by other articles:


Home page
Hum ReprodHome page
M. Metwally, S. Amer, T.C. Li, and W.L. Ledger
An RCT of metformin versus orlistat for the management of obese anovulatory women
Hum. Reprod., December 18, 2008; (2008) den454v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Utz, A. Yamamoto, P. Sluss, J. Breu, and K. K. Miller
Androgens May Mediate a Relative Preservation of IGF-I Levels in Overweight and Obese Women Despite Reduced Growth Hormone Secretion
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4033 - 4040.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. Cleveland, S. M. Eng, P. E. Abrahamson, J. A. Britton, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon
Weight Gain Prior to Diagnosis and Survival from Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. L. Ahmed, W. Thomas, and K. H. Schmitz
Interactions between Insulin, Body Fat, and Insulin-Like Growth Factor Axis Proteins
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 593 - 597.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia
Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 660 - 665.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Bremnes, G. Ursin, N. Bjurstam, S. Rinaldi, R. Kaaks, and I. T. Gram
Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. U. Rosenberg, K. Einarsdottir, E. I. Friman, S. Wedren, P. W. Dickman, P. Hall, and C. Magnusson
Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2482 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, A. H. Eliassen, S. A. Missmer, H. Baer, J. Rich-Edwards, K. B. Michels, R. L. Barbieri, M. Dowsett, and S. E. Hankinson
Birthweight and Body Size throughout Life in Relation to Sex Hormones and Prolactin Concentrations in Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2494 - 2501.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Mahabir, D. J. Baer, L. L. Johnson, T. J. Hartman, J. F. Dorgan, W. S. Campbell, B. A. Clevidence, and P. R. Taylor
Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2502 - 2507.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. B. Michels, K. L. Terry, and W. C. Willett
Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer
Arch Intern Med, November 27, 2006; 166(21): 2395 - 2402.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Henderson, M. I. Goran, L. N. Kolonel, B. E. Henderson, and L. Le Marchand
Ethnic Disparity in the Relationship between Obesity and Plasma Insulin-Like Growth Factors: The Multiethnic Cohort.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2298 - 2302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Muniyappa, K. A. Wong, H. L. Baldwin, J. D. Sorkin, M. L. Johnson, S. Bhasin, S. M. Harman, and M. R. Blackman
Dehydroepiandrosterone Secretion in Healthy Older Men and Women: Effects of Testosterone and Growth Hormone Administration in Older Men
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4445 - 4452.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. P. Beehler, M. Sekhon, J. A. Baker, B. E. Teter, S. E. McCann, K. J. Rodabaugh, and K. B. Moysich
Risk of Ovarian Cancer Associated with BMI Varies by Menopausal Status
J. Nutr., November 1, 2006; 136(11): 2881 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Sherman, J. V. Lacey, S. S. Buys, D. J. Reding, C. D. Berg, C. Williams, and P. Hartge
Ovarian Volume: Determinants and Associations with Cancer among Postmenopausal Women.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1550 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. A. Bauman, A. M. Spungen, J. Wang, R. N. Pierson Jr., and E. Schwartz
Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1098 - E1103.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. H. Eliassen, S. A. Missmer, S. S. Tworoger, and S. E. Hankinson
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer: Does the Association Vary by a Woman's Predicted Breast Cancer Risk?
J. Clin. Oncol., April 20, 2006; 24(12): 1823 - 1830.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. J. Cleveland, M. D. Gammon, S. N. Edmiston, S. L. Teitelbaum, J. A. Britton, M. B. Terry, S. M. Eng, A. I. Neugut, R. M. Santella, and K. Conway
IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project
Carcinogenesis, April 1, 2006; 27(4): 758 - 765.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke
Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats
J. Nutr., April 1, 2006; 136(4): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. dos Santos Silva, N. Johnson, B. De Stavola, G. Torres-Mejia, O. Fletcher, D. S. Allen, N. E. Allen, T. J. Key, I. S. Fentiman, J. M.P. Holly, et al.
The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I.A.A. Penna, P.R.B. Canella, R.M. Reis, M.F. Silva de Sa, and R.A. Ferriani
Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study
Hum. Reprod., September 1, 2005; 20(9): 2396 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. C. Onland-Moret, C. H. van Gils, M. Roest, D. E. Grobbee, and P. H.M. Peeters
Cyp17, Urinary Sex Steroid Levels and Breast Cancer Risk in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 815 - 820.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Bjornerem, B. Straume, M. Midtby, V. Fonnebo, J. Sundsfjord, J. Svartberg, G. Acharya, P. Oian, and G. K. R. Berntsen
Endogenous Sex Hormones in Relation to Age, Sex, Lifestyle Factors, and Chronic Diseases in a General Population: The Tromso Study
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6039 - 6047.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.